FINWIRES · TerminalLIVE
FINWIRES

Canada's Economic Update Has A Smaller Deficit This Year, But Windfall Won't Last, Says TD

By

-- Canadian government books look better than expected to end 2025-2026, with the deficit expected to be $11.4 billion smaller than expected, said TD after Tuesday's release of the Spring Economic Update.

However, much of the windfall will be spent over the budget horizon, noted the bank.

The update committed to $37.5 billion in new spending over six years, but much of it was accounted for by previously announced measures, including the enhanced GST rebate, the gasoline tax holiday and the electric vehicle rebate, pointed out TD.

New spending measures include $6 billion to expand skilled trades and the announcement of a new sovereign wealth fund.

Overall, the slightly better near-term deficit leads to a slightly lower trajectory for the federal debt burden, stated the bank. However, debt servicing costs still rise through the budget horizon.

A deeper assessment of the new Canada Strong Fund awaits clarity on many unanswered questions, according to the bank.

Related Articles

Asia

ICBC Sells 50 Billion Yuan Bonds

Industrial and Commercial Bank of China (HKG:1398, SHA:601398) or ICBC completed the issue of 50 billion yuan of four-year bonds carrying an interest rate of 1.79%, according to a Wednesday Hong Kong bourse filing.The lender has a conditional redemption right at the end of the third year.The firm intends to use proceeds to improve its total loss-absorbing capacity.

$HKG:1398$SHA:601398
Asia

DFZQ's Profit Climbs 11% in Q1

Orient Securities (HKG:3958) or DFZQ recorded an 11% rise in attributable profit in the first quarter of 2026 to 1.59 billion yuan from 1.44 billion yuan after adjustment a year prior, according to a Wednesday Hong Kong bourse filing.The securities company's basic EPS rose to 0.19 yuan from 0.16 yuan in the corresponding period of the previous fiscal year.Operating income jumped 5.3% to 4.09 billion yuan from 3.88 billion yuan in the year-ago period.

$HKG:3958
Research

Research Alert: Ionis Reports Strong Q1 Led By Commercial Momentum; Raises Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Ionis delivered robust Q1 2026 results with total revenue surging to $246M (+87% Y/Y), fueled by strong commercial execution and approximately $95M in R&D milestone payments. Product sales reached $43M compared to just $6M in the prior year period, with TRYNGOLZA generating $27M (+350% Y/Y) and DAWNZERA contributing $16M (+125% sequential growth). The accelerating momentum across its independent launch portfolio demonstrates strong commercial execution, in our view. Management raised 2026 revenue guidance substantially to $875M-$900M (from $800M-$825M) and improved operating loss guidance to $425M-$475M (from $500M-$550M). The company also increased olezarsen peak sales guidance to over $3B from over $2B, reflecting growing confidence in the severe hypertriglyceridemia market opportunity. With multiple regulatory catalysts ahead, including potential approvals for olezarsen and zilganersen, we believe Ionis appears well-positioned for continued growth.

$IONS